Topics:
Gastrointestinal Cancers • Medical Oncology
Is there a role for trastuzumab in the preoperative chemoradiation regimen for HER2 + esophageal adenocarcinoma (cT3N0)?
Answer from: Medical Oncologist at Academic Institution
Outside of a clinical trial, I would not add trastuzumab to neoadjuvant chemoradiation at this point. RTOG 1010 will shed light on the utility of trastuzumab in this setting.
Sign in or Register to read more